4jo2: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120== | ==Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120== | ||
<StructureSection load='4jo2' size='340' side='right' caption='[[4jo2]], [[Resolution|resolution]] 2.50Å' scene=''> | <StructureSection load='4jo2' size='340' side='right'caption='[[4jo2]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4jo2]] is a 6 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4jo2]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] and [https://en.wikipedia.org/wiki/Oryctolagus_cuniculus Oryctolagus cuniculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4JO2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4JO2 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4jo2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4jo2 OCA], [https://pdbe.org/4jo2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4jo2 RCSB], [https://www.ebi.ac.uk/pdbsum/4jo2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4jo2 ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | |||
[https://www.uniprot.org/uniprot/Q9YXH5_9HIV1 Q9YXH5_9HIV1] | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 20: | Line 20: | ||
==See Also== | ==See Also== | ||
*[[3D structures | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: | [[Category: Oryctolagus cuniculus]] | ||
[[Category: | [[Category: Kong XP]] | ||
[[Category: | [[Category: Pan RM]] | ||
Revision as of 14:26, 24 November 2022
Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120
Structural highlights
FunctionPublication Abstract from PubMedThe Rabbit is a commonly used animal model in studying antibody responses in HIV/AIDS vaccine development. However, no rabbit monoclonal antibodies have been developed previously to study the epitope specific antibody responses against HIV-1 envelope glycoproteins (Env), and little is known about how the rabbit immune system can mimic the human immune system in eliciting such antibodies. Here we present structural analyses of two rabbit monoclonal antibodies (mAbs), R56 and R20, against the third variable region (V3) of HIV-1 gp120. R56 recognizes the well-studied immunogenic region in the V3 crown, while R20 targets a less-studied region at the C-terminus of V3. By comparison of the Fab/epitope complex structures of these two antibodies raised by immunization with that of the corresponding human antibodies derived from patients chronically infected by HIV-1, we found that rabbit antibodies can recognize immunogenic regions of gp120 and mimic the binding modes of human antibodies. This result can provide new insight in using the rabbit as an animal model in AIDS vaccine development. Rabbit anti-HIV-1 monoclonal antibodies raised by immunization can mimic the antigen-binding modes of antibodies derived from HIV-1 infected humans.,Pan R, Sampson JM, Chen Y, Vaine M, Wang S, Lu S, Kong XP J Virol. 2013 Jul 17. PMID:23864637[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|